Q-omics provides the consensus-scored LINC00887 profile across patient tissues and cancer cell-line models. LINC00887 expression is associated with patient survival in 22 of 34 cancer types, with the highest sampling consensus in UCEC. Among the 18 cancer types available for tumor–normal comparison, LINC00887 is differentially expressed in 13, with the highest sampling consensus in KIRC. Additionally, LINC00887 RNA expression shows 12,328 significant gene co-expression associations, with the highest sampling consensus in TGCT. Together, these results highlight UCEC, KIRC, and TGCT as cancer lineages where LINC00887 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC00887 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC00887 survival associations across molecular data types. LINC00887 RNA expression shows survival associations in the most cancer types (22). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC00887 RNA expression–survival associations across cancer types. High LINC00887 expression shows unfavorable associations in UCEC, HNSC, LUAD and LGG, but favorable associations in KIRC and ACC. The UCEC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify UCEC as the clearest survival context for LINC00887 RNA expression.
This table summarizes LINC00887 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 13. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC00887. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC00887 shows lower tumor expression in KICH and higher tumor expression in KIRC, THCA, LUAD, KIRP and BRCA. The KIRC box plot shows higher LINC00887 RNA expression in tumor versus normal tissue (log2 FC = +3.946, t-test p < 0.001).
This table shows molecular features associated with LINC00887 in patient tissues and cancer cell lines. In patient samples, LINC00887 shows the broadest associations at the RNA and protein expression levels, with TGCT recurring as the lineage with the largest associated feature set.
